2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Glioblastoma
80
Prostatic Neoplasms
57
Carcinoma, Non-Small-Cell Lung
54
Breast Neoplasms
54
Esophageal Neoplasms
48
Rectal Neoplasms
42
Lung Neoplasms
42
Brain Neoplasms
34
Squamous Cell Carcinoma of Head and Neck
33
Head and Neck Neoplasms
33
Gliosarcoma
31
Pancreatic Neoplasms
29
Uterine Cervical Neoplasms
28
Neoplasms
25
Glioma
24
Neoplasm Metastasis
23
Sarcoma
22
Oropharyngeal Neoplasms
21
Esophageal Squamous Cell Carcinoma
20
Melanoma
19
Astrocytoma
18
Adenocarcinoma Of Esophagus
15
Stomach Neoplasms
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Carcinoma, Squamous Cell
12
Urinary Bladder Neoplasms
11
Mouth Neoplasms
11
Lymphoma, Follicular
11
Central Nervous System Neoplasms
11
Carcinoma
11
Interventions
Cisplatin
7
Cetuximab
5
Drug Therapy
4
Radiotherapy
3
Resistance Training
2
Radiotherapy, Intensity-Modulated
2
Nutritional Status
2
Hydroxyurea
2
Fluorouracil
2
Erlotinib Hydrochloride
2
Bevacizumab
2
zimberelimab
1
temsirolimus
1
pembrolizumab
1
Valproic Acid
1
Sirolimus
1
Radiation
1
Quality of Life
1
Psychology, Positive
1
Patient Reported Outcome Measures
1
Oncolytic Virotherapy
1
Molecular Diagnostic Techniques
1
Methods
1
Metabolic Flux Analysis
1
Immunotherapy
1
Immunoglobulin G
1
Etoposide
1
Docetaxel
1
Disulfides
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pharyngeal Neoplasms
×
Radiation
×
Clear all
NCT04892875
2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1
Withdrawn